[{"id":"28391cf3-06f6-4d40-9f4d-4cb991363ec0","acronym":"","url":"https://clinicaltrials.gov/study/NCT05366179","created_at":"2022-05-09T11:56:25.996Z","updated_at":"2024-07-02T16:35:08.155Z","phase":"Phase 1","brief_title":"Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc","source_id_and_acronym":"NCT05366179","lead_sponsor":"UNC Lineberger Comprehensive Cancer Center","biomarkers":" CD276","pipe":"","alterations":" ","tags":["CD276"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CAR.B7-H3 T"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 09/02/2022","start_date":" 09/02/2022","primary_txt":" Primary completion: 10/31/2024","primary_completion_date":" 10/31/2024","study_txt":" Completion: 05/01/2030","study_completion_date":" 05/01/2030","last_update_posted":"2024-04-23"},{"id":"93b62ffd-6a53-4b40-8d89-301b6778ce44","acronym":"","url":"https://clinicaltrials.gov/study/NCT06158139","created_at":"2023-12-06T19:17:35.778Z","updated_at":"2024-07-02T16:35:08.151Z","phase":"Phase 1","brief_title":"Autologous CAR-T Cells Targeting B7-H3 in PDAC","source_id_and_acronym":"NCT06158139","lead_sponsor":"UNC Lineberger Comprehensive Cancer Center","biomarkers":" CD276","pipe":"","alterations":" ","tags":["CD276"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CAR.B7-H3 T"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 27","initiation":"Initiation: 06/01/2024","start_date":" 06/01/2024","primary_txt":" Primary completion: 06/01/2026","primary_completion_date":" 06/01/2026","study_txt":" Completion: 06/01/2028","study_completion_date":" 06/01/2028","last_update_posted":"2024-04-23"},{"id":"9c7d7059-df8c-498d-839f-0cfa2f5fe9a9","acronym":"","url":"https://clinicaltrials.gov/study/NCT04670068","created_at":"2021-01-19T20:44:26.413Z","updated_at":"2024-07-02T16:35:08.066Z","phase":"Phase 1","brief_title":"Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian","source_id_and_acronym":"NCT04670068","lead_sponsor":"UNC Lineberger Comprehensive Cancer Center","biomarkers":" CD276 • BRCA • MUC16","pipe":" | ","alterations":" BRCA mutation","tags":["CD276 • BRCA • MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • CAR.B7-H3 T • cyclophosphamide intravenous"],"overall_status":"Recruiting","enrollment":" Enrollment 21","initiation":"Initiation: 01/27/2021","start_date":" 01/27/2021","primary_txt":" Primary completion: 02/01/2025","primary_completion_date":" 02/01/2025","study_txt":" Completion: 02/01/2030","study_completion_date":" 02/01/2030","last_update_posted":"2024-04-23"}]